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Purpose: To investigate the effect of antioxidants and immunosuppresants on mixed peripheral blood mononuclear cells
(PBMC) - chemically injured keratocytes reaction (MLKR).
Methods: The PBMC stimulation assay was performed using chemically injured keratocytes treated with 0.05 N NaOH
for 90 s (MLKR). MLKR were treated with various drugs including rapamycin, dexamethasone, mycophenoleic acid
(MPA), alpha lipoic acid (ALA), and N-acetyl cysteine (NAC). Matrix metalloprotease-9 (MMP-9), transforming growth
factor–beta 1 (TGF-β1), interleukin-6 (IL-6), and macrophage migration inhibitory factor (MIF) secretion profiles of
activated PBMCs stimulated by NaOH-treated keratocytes were determined by ELISA.
Results: Anti-oxidants as well as immunosuppressants suppressed PBMC proliferation. MMP-9 levels were lower in
antioxidants  group.  IL-6  levels  decreased  in  dexamethasone  group  and  anti-oxidants  group.  Combination  of
immunosuppressants  and  antioxidants  suppressed  more  PBMC  proliferation  except  for  rapamycin  +  ALA  group,
suppressed MMP-9 production except for MPA + ALA group, decreased IL-6 levels and increased MIF levels except for
rapamycin + ALA group. TGF-β1 levels were elevated in rapamycin group and rapamycin + ALA group.
Conclusions: Cytokine production was different depending on combination of drugs.Our results suggest that the different
drugs should be selected for treatment according to the phases of corneal chemical burn.
Corneal  chemical  burn  can  induce  a  devastating  and
permanent  damage  to  ocular  surface  resulting  in  corneal
blindness [1]. Corneal chemical burn injuries can induce a
large extent of cell death [2]. Especially, exposure to alkali
agent may cause extensive damage to ocular tissues because
alkali can progress rapidly and penetrate into deep tissues
[3]. Although there have been many studies about treatment
of  chronic  ocular  damages  including  amniotic  membrane
transplantation,  oral  mucosal  transplantation  and  limbal
transplantation  [3,4],  suppression  of  acute  and  chronic
inflammation  induced  by  chemical  burn  still  has  been
challenging.
A  variety  of  medical  therapies  including  topical  and
systemic  drugs  have  been  investigated  to  control
inflammation and promote ocular surface healing [5,6]. After
reactive oxygen species (ROS) has been reported to be able
to induce inflammation [7,8], there have been many studies to
report the effect of anti-oxidants on inflammation [2,7-10].
However, the effect of combination of immunosuppressants
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and  anti-oxidants  on  corneal  chemical  burn  has  not  been
studied.  In  this  study,  we  investigated  the  effect  of
antioxidants  and  immunosuppresants  on  mixed  peripheral
blood  mononuclear  cells  (PBMC)  -  chemically  injured
keratocytes reaction (MLKR).
METHODS
This  study  was  performed  according  to  the  tenets  of  the
Declaration of Helsinki and was reviewed and approved by
the institutional review board/ethics committee of Hallym
University Medical Center, Seoul, Republic of Korea. Human
corneal  cells,  including  human  corneal  keratocytes  and
epithelial cells, were obtained from discarded corneal–scleral
rings after penetrating keratoplasty. These tissues were stored
in Optisol™-GS (Bausch and Lomb Inc., Rochester, NY) at
4 °C until processed for culture.
Human  corneal  keratocyte  culture:  Descemet's
membrane and epithelium were removed using forceps and an
ophthalmic knife, and stroma was minced under laminar flow.
Mid-stroma  and  posterior  stroma  explants  were  then
suspended in culture medium and cultured in 24-well plates
[11-13].  The  corneal  stroma  was  sliced  into  quarters  and
digested overnight with 2.0 mg/ml collagenase (Roche, Basel,
Switzerland)  and  0.5  mg/ml  hyaluronidase  (Worthington
Biochemicals, Lakewood, NJ) in DMEM at 37 °C. Isolated
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2665cells were washed in DMEM and cultured in DMEM/F12
supplemented with 10% fetal bovine serum (FBS; Gibco-
Invitrogen, Grand Island, NY). The cells were cultured on
tissue culture-treated plastic at 4×104 cells/cm2.
PBMC isolation: Heparinized fresh whole blood (10 IU
heparin/ml) was diluted 1:2 with PBS solution. The PBMC
fraction was obtained by Ficoll-Hypaque centrifugation. The
cells were then washed in PBS before culture. The PBMCs
were cultured for 24 h at 37 °C at a density of 1×106 cells/well
in  Roswell  Park  Memorial  Institute  (RPMI)  medium
supplemented with 5% (vol/vol) fetal calf serum. The viability
of PBMCs was measured by trypan blue dye exclusion and
was  consistently  greater  than  98%.  The  cells  were  then
suspended in RPMI-1640 (Invitrogen-Life Technologies).
PBMC stimulation assay: The PBMC stimulation assay
was performed to determine immunoreactivity as previously
described  [14,15].  In  this  investigation,  mitomycin  C  and
0.05N NaOH–treated keratocytes (5×105/ml) were used as the
stimulators. They were incubated with 25 µg/ml mitomycin
C for 30 min in a 5% CO2 humidified incubator [16]. Residual
mitomycin C was removed by repeated washing (3 times) with
RPMI-1640  containing  10%  FBS.  Then  keratocytes  were
treated with 0.05N NaOH for 90 s and washed three times with
RPMI-1640 containing 10% FBS. Responding cells (1×106/
well)  and  stimulating  cells  were  cocultured  in  200  μl  of
RPMI-1640 in 96-well plates. The cocultures were incubated
with  immunosuppressants  including  25  nM  rapamycin,
10  µM  dexamethasone  and  10  µM  mycophenoleic  acid
(MPA), or anti-oxidants including 50 mM alpha lipoic acid
(ALA) and 15 mM N-acetylcysteine (NAC). The plates were
incubated for 2 days, and PBMC proliferation was measured
using a commercial bromodeoxyuridine (BrdU) proliferation
assay  kit  (Roche  Diagnostics),  according  to  the
manufacturer’s protocol. One hundred microliters of each cell
suspension with 1×106 PBMC/ml was added to 5 wells of flat
bottomed 96-well plates. Unstimulated PBMCs served as the
negative control, and phytohemagglutinin (PHA, 5 µg/ml;
Sigma Chemical Co., St. Louis, MO)-treated PBMCs as the
positive control. The optical density was measured at 450 nm
with an ELISA reader [17]. The results are expressed as mean
(SD). Proliferation rates were calculated as the percentage
increase in the number of cells between PHA-stimulated and
unstimulated cultures, after subtraction of the corresponding
blanks.
Enzyme-linked  immunosorbent  assay  (ELISA):  The
supernatant was collected after centrifugation at 300× g for 10
min, and frozen at −70 °C until used for measurement of
cytokine levels. The concentration of interleukin-6 (IL-6),
macrophage migration inhibitory factor (MIF), transforming
growth factor - β1 (TGF- β1), and matrix metalloprotease-9
(MMP-9)  in  PBMC  culture  medium  was  assayed  using
commercial human IL-6, MIF, TGF-β, and MMP-9 ELISA
kits  (R&D  Systems,  Minneapolis,  MN),  according  to  the
manufacturer’s protocols. The sensitivity limit of each ELISA
was about 500 pg/ml. In brief, anti-human MMP-9, or TGF-
β1, or MIF, or IL-6 antibody was added to each well of a 96-
well  microtiter  plate  and  incubated  overnight  at  room
temperature. Next day, each well was washed with washing
buffer. All wells were then filled with blocking buffer (pH 7.4)
containing 1% BSA and left for 1 h at room temperature. One
hundred  microliters  of  the  standard  dilutions  of  human
MMP-9, or TGF-β1, or MIF, or IL-6 of experimental samples
were dispensed into a 96-well microtiter plate coated with the
appropriate polyclonal antibody. The plate was sealed and
incubated at room temperature (RT) for 2 h. After this, the
plates were washed 4 times, and 100 μl of goat anti-human
MMP-9,  or  TGF-β1,  or  MIF,  or  IL-6  conjugated  to
horseradish peroxidase was added to each well and allowed
to incubate at RT for 2 h. One-hundred-microliter aliquots of
the color reagent 3,3′,5,5′-tetramethylbenzidine (TMB) were
then applied for 20 min to develop a blue color, and the
reaction was stopped by adding 50 μl of 1 M H2SO4. The
absorbance was measured at a wavelength of 450 nm by using
an automatic plate reader with a reference wavelength of 570
nm.
RESULTS
Culture  of  human  keratocytes:  Cultured  keratocytes  were
observed growing parallel to the etched lines (Figure 1A).
Immunofluorescence with anti-vimentin antibody, a general
marker of keratocyte, showed the morphology (Figure 1B).
The nuclei were stained with Hoechst 33342.
PBMC stimulation assay: NaOH-treated human keratocytes
served  as  the  stimulators.  Anti-oxidants  as  well  as
immunosuppressants  suppressed  the  PBMC  proliferation
(p=0.016,  0.027,  0.028,  0.016,  and  0.016,  respectively,
Mann–Whitney  U  test;  Figure  2).  The  combination  of
immunosuppressants  and  NAC  was  more  effective  in
suppression  of  PBMC  proliferation  (p=0.009,  0.009,  and
0.009,  respectively,  Mann–Whitney  U  test)  while  the
combination  of  rapamycin  and  ALA  increased  PBMC
proliferation  (p=0.009,  Mann–Whitney  U  test).
Dexamethasone + ALA group and MPA + ALA group did not
show any difference (Figure 2).
MMP-9 secretion profiles of activated PBMCs: MMP-9 levels
were lower in ALA group and NAC group (p=0.028 and
0.009, respectively, Mann–Whitney U test). The combination
of immunosuppressants and antioxidants was more effective
in  suppression  of  MMP-9  production  except  for  the
combination of MPA and ALA (p=0.028 in rapamycin + NAC
group,  0.009  in  rapamycin  +  ALA  group,  0.009  in
dexamethasone  +  NAC,  0.009  in  dexamethasone  +  ALA
group and 0.009 in MPA + NAC group, respectively, Mann–
Whitney U test; Figure 3).
IL-6  secretion  profiles  of  activated  PBMCs:  IL-6  levels
decreased in treatment with dexamethasone or anti-oxidants
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test; Figure 4). A combination of immunosuppressants and
antioxidants are more effective to suppress the production of
IL-6 (p=0.034 in rapamycin + ALA group, 0.020 in rapamycin
+ NAC group, 0.021 in dexamethasone + ALA group, 0.021
in dexamethasone + NAC group, 0.019 in MPA + ALA group,
and  0.021  in  MPA  +  NAC  group,  respectively,  Mann–
Whitney U test; Figure 4).
MIF secretion profiles of activated PBMCs: MIF levels were
not different in treatment with each drug (Figure 5). MIF
levels  were  elevated  in  treatment  with  combination  of
immunosuppressants and NAC (p=0.034, 0.034, and 0.034,
respectively, Mann–Whitney U test; Figure 5). MIF levels in
rapamycin + NAC group were higher compared to rapamycin
group (p=0.021, Mann–Whitney U test) and those in MPA +
ALA group and MPA + NAC group were higher compared to
MPA  group  (p=0.021  and  0.021,  respectively,  Mann–
Whitney U test; Figure 5).
TGF-β1  secretion  profiles  of  activated  PBMCs:  TGF-β1
levels were elevated in rapamycin group, rapamycin + ALA
group and dexamethasone + ALA group (p=0.047, 0.009, and
0.047, respectively, Mann–Whitney U test; Figure 6).
Figure 1. Identification of keratocytes. Inverted phase-contrast images (A) and immune florescent vimentin staining (B) of human keratocytes.
Keratocytes were observed growing parallel to the etched lines. Immunofluorescence with anti-vimentin antibody, a general marker of
keratocyte, showed the morphology. The nuclei were stained with Hoechst 33342 (blue). Magnification, 200×.
Figure  2.  PBMC  stimulation  test.
NaOH-treated  human  keratocytes
served as the stimulators. Anti-oxidants
as  well  as  immunosuppressants
suppressed  the  PBMC  proliferation
(Top  left).  The  combination  of
immunosuppressants  and  NAC  was
more effective in suppression of PBMC
proliferation while the combination of
immunosuppressants  and  ALA
increased  PBMC  proliferation  except
for dexamethasone.
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Corneal chemical burn injury can induce inflammation [4].
Alkali agents saponify the cellular membrane and induce cell
death  [3].  Cellular  membrane  damage  is  the  cause  of
inflammation in necrosis [5]. Necrosis induces inflammation
while  apoptosis  doesn’t  [18].  Thus,  chemically  injured
keratocyte  may  play  an  important  role  in  inducing
inflammation in corneal chemical burn. Interactions between
chemical-burned keratocyte and PBMC may play an essential
role  in  chemical  burn  because  keratocytes  are  the  major
cellular components of cornea [9]. In addition, it has been
reported that keratocyte have a functional plasticity of resident
stromal  cells  and  can  become  macrophage-like  as  a  first
response to injury or infection of the cornea [19].
In  this  study,  we  found  that  anti-oxidants  as  well  as
immunosuppressants suppress the PBMC proliferation. The
combination  of  immunosuppressants  and  NAC  was  more
effective  in  suppression  of  PBMC  proliferation.  It  was
reported that low concentrations of ROS can stimulate cellular
proliferation  as  a  second  messenger  [10,17].  ROS  are
implicated  in  the  regulation  of  several  cellular  processes
depending on their intracellular levels. Although high levels
of ROS are toxic to the cells [1,5], low levels of ROS have
various physiologic roles for appropriate signal transduction,
kinase  activation,  and  biologic  responses  associated  with
receptor signaling [6]. In addition, ROS has been described to
modulate the inflammation [7] and promote inflammatory
cytokines  [6].  Thus,  antioxidants  can  have  a  potential  to
suppress inflammation. On the other hand, the combination of
immunosuppressants and ALA increased PBMC proliferation
except  for  the  combination  of  dexamethasone  and  ALA.
Although it has been reported that ALA alone inhibits air way
inflammation  [20,21],  we  found  the  combination  of
immunosuppressants and ALA may increase inflammation on
the contrary . Further molecular-based studies are needed to
clarify these results.
MMP-9 is a collagenase IV produced by PBMCs [21,
22]. The production of MMPs by PBMC are triggered by
chemokines and cytokines produced by other inflammatory
cells at the site of inflammation [23]. MMP-9 is involved in
degradation of extracellular matrix [24]. Corneal stroma can
be thinned progressively by MMP-9 upregulation in corneal
chemical burn [25]. Suppression of MMP-9 is important to
prevent cornea from thinning. In this study, MMP-9 levels
were lower in ALA group and NAC group. The combination
of immunosuppressants and antioxidants was more effective
in  suppression  of  MMP-9  production  except  for  the
combination of MPA and ALA.
IL-6 is a proinflammatory cytokine produced by PBMC
[26]. In this study, IL-6 levels decreased in treatment with
dexamethasone  and  anti-oxidants.  The  combination  of
immunosuppressants and antioxidants are more effective to
suppress  the  production  of  IL-6.  MIF  levels  were  not
significantly different in treatment with each drug. MIF levels
increased  in  MLKR  treated  with  the  combination  of
immunosuppressants  and  antioxidants  except  for  the
combination of rapamycin and ALA. MIF has been described
to be an innate immunity molecule leading to induction of
proinflammatory activities [27]. MIF was originally described
as a regulator of macrophage responses [27]. It directly or
Figure 3. MMP-9 levels measured by
ELISA. MMP-9 levels were lower in
ALA group and NAC group (Top left).
The  combination  of
immunosuppressants  and  antioxidants
was  more  effective  in  suppression  of
MMP-9  production  except  for  the
combination of MPA and ALA.
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inflammatory  cytokines  including  IL-6,  TNF-alpha,  IL-8
[28-30], MMP-9 [31], and TGF-β1 [32,33]. MIF levels were
elevated  in  the  groups  which  showed  lower  PBMC
proliferation rates and lower IL-6 levels in this study. MIF
might be elevated as a master regulator of inflammation [8,
29] in response to suppression of inflammation. TGF-β1 is a
multifunctional cytokine that participates in a wide range of
biologic events, including inflammation and wound repair
[32].  TGF-β1  induces  synthesis  and  accumulation  of
extracellular matrix protein and has been implicated as the
potent and key mediator of fibrogenesis [33]. TGF-β1 has
Figure  4.  IL-6  levels  measured  by
ELISA.  IL-6  levels  decreased  in
treatment with dexamethasone and anti-
oxidants (Top left). The combination of
immunosuppressants  and  antioxidants
are  more  effective  to  suppress  the
production of IL-6 .
Figure  5.  MIF  levels  measured  by
ELISA. MIF levels were not different in
treatment with each drug (Top left). MIF
levels increased in MLKR treated with
the  combination  of
immunosuppressants  and  antioxidants
except for the combination of rapamycin
and ALA.
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2669been reported to be induced by MIF in IgA nephropathy [33]
while reduced TGF-β1 and increased MIF has been described
in severe malaria [34]. In this study, TGF-β1 levels were
elevated only in rapamycin group and rapamycin + ALA
group. TGF-β1 plays an essential role in corneal chemical
burn via inducing inflammation and repairing wound [35].
TGF-  β1inducing  transdifferentiation  from  keratocyte  to
myofibroblast contribute these processes [35].
In  conclusion,  anti-oxidants  as  well  as
immunosuppressants  suppressed  the  PBMC  proliferation
induced by chemically injured keratocyte. The combination
of  immunosuppressants  and  anti-oxidants  had  a  synergic
effect  on  MLKR.  Cytokine  production  was  different
depending on the combination of drugs. Our results suggest
that  the  different  drugs  should  be  selected  for  treatment
according to the phases of corneal chemical burn. Further
study  is  necessary  to  investigate  the  interaction  between
immunosuppressants and antioxidants.
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